335
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Apoptotic death mode of mitomycin C-treated HeLa cells and cellular localization of mitomycin C–induced P-glycoprotein

, , , , , , , , & show all
Pages 158-168 | Accepted 03 Nov 2008, Published online: 01 Apr 2009

References

  • Bergstrom TJ, Wilkinson WS, Skuta GL, Watnick RL, Elner VM. (1991). The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits. Arch Ophthalmol 109:1725–1730.
  • Bohacová, V, Kvackajova J, Barancik M, Drobna Z, Breier A. (2000). Glutathione S-transferase does not play a role in multidrug resistance of L1210/VCR cell line. Physiol Res 49:447–453.
  • Bozsakyova E, Chalupa I, Sebova L, Slamenova D. (2001). Chromosomal aberrations, sister chromatid exchanges, and micronuclei induced by pentoxifylline in in vitro cultivated Chinese hamster cells (V79) and human blood lymphocytes. Mutat Res 497:63–70.
  • Bradshaw DM, Arceci RJ. (1998). Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol 16:3674–3690.
  • Cornwell MM, Safa AR, Felsted RL, Gottesman MM, Pastan I. (1986). Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci U S A 83:3847–3850.
  • Hamada H, Tsuruo T. (1988). Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase. J Biol Chem 263:1454–1458.
  • Hayes MC, Birch BR, Cooper AJ, Primrose JN. (2001). Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1). Brit J Urol Inter 87:245–250.
  • Higgins CF, Hiles ID, Salmond GP, Gill DR, Downie JA, Evans IJ, et al. (1986). A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature 323:448–450.
  • Hotta T, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Noguchi K, et al. (1999). P-glycoprotein-expressing tumor cells are resistant to anticancer drugs in human gastrointestinal cancer. Surg Today 29:591–596.
  • Huang CR, Lin SS, Chou MY, Ho CC, Wang L, Lee YL, et al. (2005). Demonstration of different modes of cell death upon herpes simplex virus 1 infection in different types of oral cells. Acta Virol 49:7–15.
  • Ihnat MA, Nervi AM, Anthony SP, Kaltreider RC, Warren AJ, Pesce CA, et al. (1999). Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice. Oncol Res 11:303–310.
  • Jampel HD. (1992). Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon’s capsule fibroblasts. Ophthalmology 99:1471–1476.
  • Kelly JD, Williamson KE, Weir HP, McManus DT, Hamilton PW, Keane PF, et al. (2000). Induction of apoptosis by mitomycin-C in an ex vivo model of bladder cancer. Brit J Urol Inter 85:911–917.
  • Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G. (1992). Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon’s capsule fibroblasts. Arch Ophthalmol 110:1150–1154.
  • Krishnaja AP, Sharma NK. (2003). Ascorbic acid potentiates mitomycin C–induced micronuclei and sister chromatid exchanges in human peripheral blood lymphocytes in vitro. Teratog Carcinog Mutagen Suppl 1:99–112.
  • Ling V, Charles F, Kettering P. (1992). P-glycoprotein and resistance to anticancer drugs. Cancer 69:2603–2609.
  • Liu J, Wang Q, Wang X, Sun Y, Chen XY, Kong Q, et al. (2003). Apoptosis of bladder cancer cells induced by short-term and low-dose mitomycin-C: potential molecular mechanism and clinical implication. Inter J Mol Med11:389–394.
  • Monden N, Abe S, Hishikawa Y, Yoshimura H, Kinugasa S, Dhar DK, et al. (1999). The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy. Inter J Surg Invest 1:3–10.
  • Nakano H, Shinohara K. (2002). Time sequence analysis of caspase-3-independent programmed cell death and apoptosis in X-irradiated human leukemic MOLT-4 cells. Cell Tissue Res 310:305–311.
  • Park IC, Park MJ, Hwang CS, Rhee CH, Whang DY, Jang JJ, et al. (2000). Mitomycin C induces apoptosis in a caspases-dependent and Fas/CD95-independent manner in human gastric adenocarcinoma cells. Cancer Lett 158:125–132.
  • Parkins CS, Denekamp J, Chaplin DJ. (1993). Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumour. Anticancer Res 13:1437–1442.
  • Plosker GL, Faulds D. (1993). Epirubicin, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs 45:788–856.
  • Poleková L, Barancik M, Mrazova T, Pirker R, Wallner J, Sulova Z, et al. (1992). Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Neoplasma 39:73–77.
  • Ruiz-Gomez MJ, Souviron A, Martinez-Morillo M, Gil L. (2000). P-glycoprotein, glutathione, and glutathione S-transferase increase in a colon carcinoma cell line by colchicine. J Physiol Biochem 56:307–312.
  • Sartorelli AC, Hodnick WF, Belcourt MF, Tomasz M, Haffty B, Fischer JJ, Rockwell S. (1994). Mitomycin C: a prototype bioreductive agent. Oncol Res 6(10–11):501–508.
  • Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, et al. (1995). Potentiation of apoptosis by treatment with the protein kinase C–specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J Natl Cancer Inst 87:1394–1399.
  • Shapiro AB, Ling V. (1995). Using purified P-glycoprotein to understand multidrug resistance. J Bioenerg Biomembr 27:7–13.
  • Singh G, Wilson MR, Foster CS. (1988). Mitomycin eye drops as treatment for pterygium. Ophthalmology 95:813–821.
  • Smith S, D’Amore PA, Dreyer EB. (1994). Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 118:332–337.
  • Sulová Z, Macejova D, Seres M, Sedlak J, Brtko J, Breier A. (2008). Combined treatment of P-gp-positive L1212/VCR cells by verapamil and all-trans retinoic acid induces downregulation of P-glycoprotein expression and transport activity. Vitro Mol Toxicol 22:96–105.
  • Thornton I, Xu M, Krueger RR. (2008). Comparison of standard (0.02%) and low-dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. J Refract Surg 24:S68–S76.
  • Tomasz M, Lipman R, Chowdary D, Pawlak J, Verdine GL, Nakanishi K. (1987). Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 235:1204–1208.
  • Vogl TJ, Zangos S, Eichler K, Selby JB, Bauer RW. (2008). Palliative hepatic intra-arterial chemotherapy (HIC) using a novel combination of gemcitabine and mitomycin C: results in hepatic metastases. Eur Radiol 18:468–476.
  • Wartenberg M, Fischer K, Hescheler J, Sauer H. (2002). Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors. Biochim Biophys Acta 1589:49–62.
  • Wei HB, Hu BG, Han XY, Zheng ZH, Wei B, Huang JL. (2008). Effect of all-trans retinoic acid on drug sensitivity and expression of survivin in LoVo cells. Chin Med J 121:331–335.
  • Xu FL, Lee YL, Tsai WY, Lin SJ, Yang ZQ, Yang CC, et al. (2005). Effect of cordycepin on Hantaan virus 76-118 infection of primary human embryonic pulmonary fibroblasts-characterization of apoptotic effects. Acta Virol 49:183–193.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.